Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-02

Clinical Trial Update: Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC) [NA]

View source ↗

Summary

This entry notes that a clinical trial evaluating taVNS for insomnia in people with breast cancer has completed; no outcome data are provided in the summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • taVNS (transcutaneous auricular vagus nerve stimulation) (transcutaneous auricular vagus nerve stimulation)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Breast Cancer, Insomnia | NA | Status: COMPLETED